Steris Plc (NYSE:STE) CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, October 4th. The shares were sold at an average price of $90.50, for a total value of $905,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Steris Plc (NYSE:STE) traded down 0.56% during mid-day trading on Friday, hitting $90.51. The stock had a trading volume of 271,653 shares. The company has a 50 day moving average price of $86.95 and a 200-day moving average price of $79.82. Steris Plc has a one year low of $63.80 and a one year high of $91.18. The company has a market cap of $7.71 billion, a price-to-earnings ratio of 64.74 and a beta of 1.29.

Steris Plc (NYSE:STE) last issued its earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 EPS for the quarter, beating the Zacks’ consensus estimate of $0.80 by $0.05. Steris Plc had a net margin of 4.63% and a return on equity of 11.39%. The business had revenue of $608.00 million for the quarter, compared to the consensus estimate of $597.66 million. During the same quarter last year, the firm posted $0.79 EPS. The business’s revenue for the quarter was down 4.8% compared to the same quarter last year. Equities analysts expect that Steris Plc will post $4.06 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 28th. Stockholders of record on Tuesday, August 29th were paid a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.37%. The ex-dividend date was Friday, August 25th. This is an increase from Steris Plc’s previous quarterly dividend of $0.28. Steris Plc’s dividend payout ratio (DPR) is currently 88.57%.

ILLEGAL ACTIVITY NOTICE: “Walter M. Rosebrough, Jr. Sells 10,000 Shares of Steris Plc (STE) Stock” was first posted by American Banking News and is the property of of American Banking News. If you are viewing this story on another site, it was illegally stolen and reposted in violation of international copyright and trademark legislation. The original version of this story can be viewed at https://www.americanbankingnews.com/2017/10/06/walter-m-rosebrough-jr-sells-10000-shares-of-steris-plc-ste-stock.html.

A number of institutional investors have recently added to or reduced their stakes in the stock. Private Harbour Investment Management & Counsel LLC increased its stake in Steris Plc by 0.4% during the 2nd quarter. Private Harbour Investment Management & Counsel LLC now owns 10,424 shares of the medical equipment provider’s stock worth $850,000 after buying an additional 40 shares during the period. Van ECK Associates Corp increased its stake in Steris Plc by 0.4% during the 1st quarter. Van ECK Associates Corp now owns 10,770 shares of the medical equipment provider’s stock worth $748,000 after buying an additional 45 shares during the period. Sawtooth Solutions LLC increased its stake in Steris Plc by 1.3% during the 2nd quarter. Sawtooth Solutions LLC now owns 4,232 shares of the medical equipment provider’s stock worth $345,000 after buying an additional 54 shares during the period. Advisor Group Inc. increased its stake in Steris Plc by 1.4% during the 2nd quarter. Advisor Group Inc. now owns 6,577 shares of the medical equipment provider’s stock worth $506,000 after buying an additional 91 shares during the period. Finally, TD Asset Management Inc. increased its stake in Steris Plc by 0.9% during the 2nd quarter. TD Asset Management Inc. now owns 23,540 shares of the medical equipment provider’s stock worth $1,919,000 after buying an additional 200 shares during the period. 93.33% of the stock is currently owned by hedge funds and other institutional investors.

A number of research firms have recently weighed in on STE. BidaskClub lowered Steris Plc from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Raymond James Financial, Inc. upped their price objective on Steris Plc from $90.00 to $95.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 9th. Finally, Zacks Investment Research raised Steris Plc from a “hold” rating to a “buy” rating and set a $92.00 price objective on the stock in a research report on Tuesday, July 11th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $86.75.

About Steris Plc

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.

Insider Buying and Selling by Quarter for Steris Plc (NYSE:STE)

Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with MarketBeat.com's FREE daily email newsletter.